Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/25 09:07 | 6/25/25 | RZLT | Health | Drug | Pharmaceutical Preparations | Roberts Brian Kenneth | CA | O | Chief Me | 1 | P | 11 | 4.38 | 0 | 3 | 1 | 174 | D | ||||||||||||||
6/24/25 12:41 | 6/24/25 | RZLT | Health | Drug | Pharmaceutical Preparations | Evans Daron | CA | O | CFO | 5 | P.e | 215 | 3.95 | 0 | 55 | 18 | 361 | D | ||||||||||||||
6/23/25 09:38 | 6/13/25 | RZLT | Health | Drug | Pharmaceutical Preparations | Kim Young-Jin | CA | D | 2 | P.d | 9,000 | 3.63 | 0 | 2,481 | 41 | 8,573 | I | |||||||||||||||
6/23/25 09:12 | 6/13/25 | RZLT | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | CA | D | 1 | P | 10 | 3.25 | 0 | 3 | 9 | 38 | D | |||||||||||||||
4/1/25 15:52 | 3/31/25 | RZLT | Health | Drug | Pharmaceutical Preparations | Hogenhuis Wladimir | CA | D | 4 | P.d | 107 | 4.13 | 0 | 26 | 44 | 84 | D | |||||||||||||||
3/31/25 09:18 | 3/27/25 | RZLT | Health | Drug | Pharmaceutical Preparations | Elam Nevan C | CA | DO | CEO | 1 | P | 35 | 2.85 | 0 | 12 | 6 | 224 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |